A Dose Escalation Study of Intranasal Neuropeptide Y in PTSD (PTSD)
A Dose Escalation Study of Intranasal Neuropeptide Y in PTSD
This study has finished and is no longer accepting participants.
In New York
Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
A Dose Escalation Study of Intranasal Neuropeptide Y in PTSD
This study has finished and is no longer accepting participants.
In New YorkA Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder
This study has finished and is no longer accepting participants.
In Oakland ParkA Phase 2, Multi-center, Randomized, Double-Blind, Parallel-Group, Dose-Finding Study to Assess the Effect of Four Doses of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockResearchers compared OPC-34712 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
In Kanto RegionDose-proportionality Study of the Five ER OROS Paliperidone To-be-marketed Tablet Strengths (3, 6, 9, 12, and 15 mg) in Healthy Male Subjects
This study has finished and is no longer accepting participants.
Location not clearly listedResearchers compared ABT-894, placebo and atomoxetine, tracking side effects to assess safety in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including San FranciscoResearchers compared ABT-089 and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including MesaResearchers compared ENX-102 and placebo, tracking side effects to assess safety and tolerability in people with an anxiety condition.
This study has finished and is no longer accepting participants.
Multiple locations, including LiverpoolA randomised, double-blind, active placebo-controlled, parallel groups dose-response study of intravenous scopolamine in major depressive disorder
This study has finished and is no longer accepting participants.
In New ZealandThis study is no longer accepting new participants.
In BostonA Double Blind Clinical Trial of DCS for Food Anxiety for Patients With Anorexia and Bulimia Nervosa
This study has finished and is no longer accepting participants.
In St LouisA Double Blind Crossover Study on the Effect of Methylphenidate on Decision-making Ability of Adults With Borderline Personality Disorder (BPD) Compared to Adults With Attention Deficit Hyperactivity Disorder (ADHD) and Healthy Adults
Current recruitment status is unconfirmed.
In Hod HaSharonWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.